Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 94
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can personalized medicine subtype bladder cancer?

    Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    How Do Fats Help Us Treat Brain Cancer?

    Malignant Brain Tumors will kill over 13,000 cancer patients this year in the United States alone; brain tumors...

    Backer Badge Funded